Literature DB >> 9795069

Drug targeting using low density lipoprotein (LDL): physicochemical factors affecting drug loading into LDL particles.

A Kader1, P J Davis, M Kara, H Liu.   

Abstract

Low density lipoprotein (LDL) has been found suitable as a targeting carrier for cytotoxic drugs. However, higher drug loading into LDL particles without disrupting their native integrity remains a major obstacle. The purpose of this study is to investigate the different physicochemical factors that may affect drug loading and to characterize LDL-drug conjugates. Doxorubicin (Dox) and 3', 5'-O-dipalmitoyl-5-iodo-2'-deoxyuridine (dpIUdR) were used as reference cytotoxic drugs. Drugs were loaded into LDL particles using the dry film method with or without surfactants, liposomal and the direct addition method. The effects of incubation temperature, time and stoichiometry of LDL-drug conjugates on drug loading were investigated. The LDL-drug conjugates were evaluated for their stability and characterized by differential scanning calorimetry (DSC), denatured gel (SDS-PAGE), and electron microscopy (EM). We have suitably incorporated 45+/-10 Dox and 150+/-25 dpIUdR molecules/LDL particle. A seven-fold increase in Dox incorporation was achieved with the liposomal preparation compared to the dry film method. A 4- to 6-h incubation at 37 degreesC was suitable to restore the native structure of LDL particles. No apo B fragmentation of LDL particles was noted on denatured gel. DSC studies showed no change in the Tm of the LDL and the LDL-drug conjugates. An increase in particle size of LDL-dpIUdR, not LDL-Dox was observed in EM compared to the native LDL which may be related to higher incorporation of dpIUdR. The results indicate that physicochemical factors significantly affect drug loading efficiency and may need to be considered to optimize drug incorporation into LDL particles.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9795069     DOI: 10.1016/s0168-3659(98)00052-2

Source DB:  PubMed          Journal:  J Control Release        ISSN: 0168-3659            Impact factor:   9.776


  10 in total

1.  Low-density lipoprotein-mediated delivery of docosahexaenoic acid selectively kills murine liver cancer cells.

Authors:  Lacy Reynolds; Rohit S Mulik; Xiaodong Wen; Archana Dilip; Ian R Corbin
Journal:  Nanomedicine (Lond)       Date:  2014-01-07       Impact factor: 5.307

Review 2.  Subcellular targeting strategies for drug design and delivery.

Authors:  Lawrence Rajendran; Hans-Joachim Knölker; Kai Simons
Journal:  Nat Rev Drug Discov       Date:  2010-01       Impact factor: 84.694

3.  High-density lipoprotein as a potential carrier for delivery of a lipophilic antitumoral drug into hepatoma cells.

Authors:  Bin Lou; Xue-Ling Liao; Man-Ping Wu; Pei-Fang Cheng; Chun-Yan Yin; Zheng Fei
Journal:  World J Gastroenterol       Date:  2005-02-21       Impact factor: 5.742

Review 4.  Lipids changes in liver cancer.

Authors:  Jing-Ting Jiang; Ning Xu; Xiao-Ying Zhang; Chang-Ping Wu
Journal:  J Zhejiang Univ Sci B       Date:  2007-06       Impact factor: 3.066

5.  Low density lipoprotein mimic nanoparticles composed of amphipathic hybrid peptides and lipids for tumor-targeted delivery of paclitaxel.

Authors:  Junyi Qian; Ningze Xu; Xu Zhou; Kaihong Shi; Qian Du; Xiaoxing Yin; Ziming Zhao
Journal:  Int J Nanomedicine       Date:  2019-09-11

Review 6.  Lipoprotein-Related and Apolipoprotein-Mediated Delivery Systems for Drug Targeting and Imaging.

Authors:  Gunter Almer; Harald Mangge; Andreas Zimmer; Ruth Prassl
Journal:  Curr Med Chem       Date:  2015       Impact factor: 4.530

Review 7.  Lipoprotein Drug Delivery Vehicles for Cancer: Rationale and Reason.

Authors:  Jaideep Chaudhary; Joseph Bower; Ian R Corbin
Journal:  Int J Mol Sci       Date:  2019-12-15       Impact factor: 5.923

8.  Cancer targeted drug delivery using active low-density lipoprotein nanoparticles encapsulated pyrimidines heterocyclic anticancer agents as microtubule inhibitors.

Authors:  Laila Jaragh-Alhadad; Haider Behbehani; Sadashiva Karnik
Journal:  Drug Deliv       Date:  2022-12       Impact factor: 6.819

9.  Mammaglobin as a potential molecular target for breast cancer drug delivery.

Authors:  Lian Zuo; Ly Li; Qian Wang; Timothy P Fleming; Shaojin You
Journal:  Cancer Cell Int       Date:  2009-03-23       Impact factor: 5.722

10.  Crosstalk of low density lipoprotein and liposome as a paradigm for targeting of 5-fluorouracil into hepatic cells: cytotoxicity and liver deposition.

Authors:  Saleh A Alanazi; Gamaleldin I Harisa; Mohamed M Badran; Fars K Alanazi; Ehab Elzayat; Abdullah H Alomrani; Osaid T Al Meanazel; Ahmed T Al Meanazel
Journal:  Bioengineered       Date:  2021-12       Impact factor: 3.269

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.